Recombinant zoster vaccine vs placebo
Adverse effects of any severity (systemic symptoms) · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine probably leads to higher participants with adverse events ‐ any systemic symptomClinical… compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2.23 [2.12, 2.34]2 studies · 9762 participantsModerate